Our patients had a mean age of 67.6 years, a majority of Gleason 7 prostate cancer (80%), and a median PSA level before PET of 0.682 ng/mL (min 0.23 ng/mL–max 20 ng/mL). The gene discussed is KLK3; the disease is prostate carcinoma.